Monday, July 25, 2016

BRIEF-Pharmaengine sayss Onivyde(r) regimen receives CHMP positive opinion

* Pharmaengine announces Onivyde(r) regimen receives CHMP

positive opinion for the treatment of metastatic pancreatic

cancer

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)